Xie L - Search Results

1

Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.

Jiang B, Zhu H, Tang L, Gao T, Zhou Y, Gong F, Tan Y, Xie L, Wu X, Li Y. Jiang B, et al. Among authors: xie l. Anticancer Agents Med Chem. 2022;22(9):1723-1734. doi: 10.2174/1871520621666210412103849. Anticancer Agents Med Chem. 2022. PMID: 33845750

2

Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.

Li Y, Jiang B, Wu X, Huang Q, Chen W, Zhu H, Qu X, Xie L, Ma X, Huang G. Li Y, et al. Among authors: xie l. Biochem Biophys Res Commun. 2018 Sep 3;503(1):45-50. doi: 10.1016/j.bbrc.2018.05.146. Epub 2018 Jun 15. Biochem Biophys Res Commun. 2018. PMID: 29792859

3

circIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression.

Li Y, Jiang B, He Z, Zhu H, He R, Fan S, Wu X, Xie L, He X. Li Y, et al. Among authors: xie l. Aging (Albany NY). 2020 Aug 3;12(15):15532-15545. doi: 10.18632/aging.103746. Epub 2020 Aug 3. Aging (Albany NY). 2020. PMID: 32756009 Free PMC article.

4

Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.

He P, Wang Z, Sheng B, Xu Y, Feng S, Huang Y, Gong F, Tang L, Xie L. He P, et al. Among authors: xie l. Histol Histopathol. 2020 Dec;35(12):1511-1520. doi: 10.14670/HH-18-299. Epub 2020 Dec 29. Histol Histopathol. 2020. PMID: 33372687

5

The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer.

Tang L, Jiang B, Zhu H, Gao T, Zhou Y, Gong F, He R, Xie L, Li Y. Tang L, et al. Among authors: xie l. Front Oncol. 2021 Feb 25;11:605988. doi: 10.3389/fonc.2021.605988. eCollection 2021. Front Oncol. 2021. PMID: 33718157 Free PMC article. Review.

6

Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase I and II dual inhibitors for the therapy of liver cancer.

Deng X, Luo T, Zhang X, Li Y, Xie L, Jiang W, Liu L, Wang Z. Deng X, et al. Among authors: xie l. Eur J Med Chem. 2022 Jul 5;237:114376. doi: 10.1016/j.ejmech.2022.114376. Epub 2022 Apr 18. Eur J Med Chem. 2022. PMID: 35462164

7

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Xie J, Zou Y, Gao T, Xie L, Tan D, Xie X. Xie J, et al. Among authors: xie x, xie l. Cancer Control. 2022 Jan-Dec;29:10732748221099230. doi: 10.1177/10732748221099230. Cancer Control. 2022. PMID: 35499382 Free PMC article.

8

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients.

Wen W, Jiang B, Cao X, Xie L, Zhang X, Li Y, He R. Wen W, et al. Among authors: xie l. Front Oncol. 2022 May 6;12:882328. doi: 10.3389/fonc.2022.882328. eCollection 2022. Front Oncol. 2022. PMID: 35600360 Free PMC article.

9

Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.

Jiang B, Zhu H, Feng W, Wan Z, Qi X, He R, Xie L, Li Y. Jiang B, et al. Among authors: xie l. Dis Markers. 2022 Oct 19;2022:9004830. doi: 10.1155/2022/9004830. eCollection 2022. Dis Markers. 2022. PMID: 36312586 Free PMC article.

10

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.

Qi X, Wan Z, Jiang B, Ouyang Y, Feng W, Zhu H, Tan Y, He R, Xie L, Li Y. Qi X, et al. Among authors: xie l. Front Immunol. 2022 Nov 24;13:1038225. doi: 10.3389/fimmu.2022.1038225. eCollection 2022. Front Immunol. 2022. PMID: 36505465 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,004 results

Search Page

Filters